FDA Orange Book · active-ingredient family
Urea c-13
Urea c-13 is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:BREATHTEK UBT FOR H-PYLORI · NDA 020586
3
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · for solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| BREATHTEK UBT FOR H-PYLORI×2 | OTSUKA AMERICA | NDA 020586 | — | May 10, 2001 | |
| HELICOSOL | METABOLIC SOLUTIONS | NDA 021092 | — | Dec 17, 1999 | |
| PYLORI-CHEK BREATH TEST | DXS DEVICES | NDA 020900 | — | Feb 04, 1999 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Urea c-13 — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

